Shô Miyamoto

919 citations
41 papers · 414 indexed · h-index 10
Topics
SARS-CoV-2 and COVID-19 Research (11 papers)COVID-19 Clinical Research Studies (9 papers)SARS-CoV-2 detection and testing (6 papers)

In The Last Decade

Shô Miyamoto

36 papers receiving 379 citations

Peers

Shô Miyamoto
Comparison fields: 5 of 88
  • Molecular Biology 184
  • Infectious Diseases 80
  • Cellular and Molecular Neuroscience 79
  • Immunology 44
  • Epidemiology 43
Replace Henning Cramer with:
Henning Cramer Germany
Jennifer Phillips United States
Sophie Tuffet France
F. Ménard France
Mark Hughes United Kingdom
Mi Young Kim South Korea
Worawit Suphamungmee Thailand
Linda Yu-Ling Lan United States
Sandra Ebert Germany
Richard Gilbert United Kingdom
Shô Miyamoto relative to Henning Cramer Germany Henning Cramer's profile →
Citations per field
00.5×8.4×
Henning Cramer · 1×
Citations per year

Countries citing papers authored by Shô Miyamoto

Since Specialization
Citations

This map shows the geographic impact of Shô Miyamoto's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Shô Miyamoto with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Shô Miyamoto more than expected).

Fields of papers citing papers by Shô Miyamoto

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Shô Miyamoto. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Shô Miyamoto. The network helps show where Shô Miyamoto may publish in the future.

Co-authorship network of co-authors of Shô Miyamoto

This figure shows the co-authorship network connecting the top 25 collaborators of Shô Miyamoto. A scholar is included among the top collaborators of Shô Miyamoto based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Shô Miyamoto. Shô Miyamoto is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
#WorkIndexed citations
1 2
2 0
3 0
4 2
5 7
6 0
7 6
8 14
9 2
10 0
11 1
12 4
13 16
14 3
15 6
16 18
17 2
18 5
19 4
20 1

About Shô Miyamoto

Shô Miyamoto is a scholar working on Infectious Diseases, Filtration and Separation and Oral Surgery, having authored 41 papers that have together received 414 indexed citations. Recurring topics across this work include SARS-CoV-2 and COVID-19 Research (11 papers), COVID-19 Clinical Research Studies (9 papers) and SARS-CoV-2 detection and testing (6 papers). The work is most often cited by research in Physiology (34 citations), Cellular and Molecular Neuroscience (79 citations) and Infectious Diseases (80 citations). Shô Miyamoto has collaborated with scholars based in Japan, United States and Germany. Frequent co-authors include K. Koketsu, Leo G. Abood, Takeshi Noda, Tadaki Suzuki, Hiroshi Nagasaki, Naoko Sasaki, Yutaka Oiso, Michiho Ito, H Saito and Hideya Yuasa. Their work appears in journals such as Nature, The Journal of Clinical Endocrinology & Metabolism and Scientific Reports.

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026